Type 1 Regulatory T Cells and Regulatory B Cells Induced by Tolerogenic Dendritic Cells
Authors:
- 26 March 2013
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 77 (4) , 246-254
Abstract
Dendritic cells (DC) are professional antigen‐presenting cells that are capable of both activating immune responses and inducing tolerance. Several studies have revealed efficiency of therapeutic vaccination with tolerogenic DC (tolDC) in inhibition of experimental autoimmunity. The purpose of this study was to compare four different protocols for generation of tolDC – the antidiabetic drug troglitazone (TGZ DC), NF‐κB inhibitor BAY 11‐7082 (BAY DC), prostaglandin D2 metabolite 15d‐PGJ2 (PGJ DC) and a combination of dexamethasone and 1α,25‐dihydroxyvitamin D3 (DexVD3 DC) regarding phenotype, cytokine production and T cell stimulatory capacity. TGZ DC and BAY DC had a phenotype comparable to immature DC, while DexVD3 DC were more macrophage like. Analysis of cytokine production using cell culture supernatants from all DC populations revealed that DexVD3 DC were efficient producers of IL‐10 and produced less pro‐inflammatory cytokines. T cells primed with DexVD3 DC showed reduced proliferation, and further analyses of these T cells revealed that functionally effective type 1 regulatory T cells (Tr1) but not FoxP3+ Treg were induced. Furthermore, DexVD3 DC promoted the induction of regulatory B cells (Breg). Together, these results indicate that DexVD3 DC have the best potential to be used in a tolerogenic antigen‐presenting cell‐based immunotherapy setting.Keywords
This publication has 40 references indexed in Scilit:
- A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitusCurrent Opinion in Endocrinology, Diabetes and Obesity, 2012
- Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritisArthritis Research & Therapy, 2012
- Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic PatientsDiabetes Care, 2011
- Comparative study of clinical grade human tolerogenic dendritic cellsJournal of Translational Medicine, 2011
- Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cellsBlood, 2011
- Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseasesJournal of Autoimmunity, 2009
- Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor functionJournal of Translational Medicine, 2009
- LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cellsJournal of Leukocyte Biology, 2008
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory ResponsesImmunity, 2008
- Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell developmentProceedings of the National Academy of Sciences, 2006